Souvien Therapeutics
Salt Lake City
About Souvien Therapeutics
Souvien Therapeutics is a biotechnology company focused on developing therapeutic agents to modulate critical epigenetic mechanisms associated with neurodegeneration.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $3.5M
- Last round: Series Unknown (May 2019)
- Phone: 1 860 208 0042
Industries & Categories
Biotechnology, Pharmaceutical
Canonical: https://fsome.com/organization/souvien-therapeutics-136699 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.